Legal Representation
Attorney
PETER SLOANE
USPTO Deadlines
Next Deadline
70 days remaining
Non-Final Action E-Mailed
Due Date
April 05, 2026
Extension Available
Until July 05, 2026
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 5, 2026 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 5, 2026 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 5, 2026 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 8, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 8, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 8, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Dec 4, 2025 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Oct 2, 2025 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Oct 2, 2025 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Oct 2, 2025 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Jul 14, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 14, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 14, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 5, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 5, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 5, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 5, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 5, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Apr 4, 2025 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Apr 4, 2025 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Apr 4, 2025 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Apr 4, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 4, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 3, 2025 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Jan 16, 2025 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Jan 16, 2025 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Jan 16, 2025 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Jul 18, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 18, 2024 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 18, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jul 17, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 17, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 17, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 30, 2024 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Nov 16, 2023 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Nov 16, 2023 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Nov 16, 2023 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| May 19, 2023 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| May 19, 2023 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| May 19, 2023 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Apr 26, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 25, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 25, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 31, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 31, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 31, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 24, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 1, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 1, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 4, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Detailed Classifications
Class 005
Cannabis related products, namely, medicated oils, salves, tinctures, tablets and capsules, each containing cannabis for
medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining
general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid
addiction and relief of epilepsy; oils, salves, tinctures, tablets and capsules each containing resins and oils derived from cannabis
for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining
general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid
addiction and relief of epilepsy; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and
fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a
sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing cannabis
for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and
well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of
epilepsy; nutraceuticals for medicinal purposes containing derivatives of cannabis, namely, resins and oils for the relief of pain, for
relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving
anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; medicated topical
skin creams, bar and liquid soaps, bath additives, bath herbs, bath oils, body creams, body oils, face and body lotions, face and
body milk, face lotion, and skin care preparations each containing derivatives of cannabis, for the relief of pain, for relaxation, for
reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for
relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; personal sexual lubricants;
transdermal patches containing cannabis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood
enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for
management of opioid addiction and relief of epilepsy; oral sprays containing cannabis for medicinal use for the relief of pain, for
relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving
anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; cannabis for
medicinal purposes, namely, gummy vitamins for the relief of pain, for relaxation, for reducing stress and fatigue, for mood
enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for
management of opioid addiction and relief of epilepsy; cannabis related product, namely, oils for medicinal use for the relief of
pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for
relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils
derived from cannabis for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood
enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for
management of opioid addiction and relief of epilepsy; none of the foregoing containing cannabis with a delta-9
tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis
Class 031
Live cannabis plants; Cannabis seeds for agricultural purposes; derived solely from hemp plants containing no more than .3
percent delta-9 tetrahydrocannabinol (THC) concentration by dry weight basis
Class 041
Providing entertainment information in the field of cannabis culture via a website; providing news via a website in the nature of
current event reporting in the field of cannabis and cannabis culture; providing educational information in the field of cannabis-themed cultural events and festivals via a website
Class 042
Research services, namely, medical, scientific, foods, cosmetic, product, and agricultural research in the area of cannabis,
cannabis related products, derivatives of cannabis, and natural health products containing cannabis; none of the foregoing
services featuring or providing cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a
dry weight basis
Class 044
Providing the breeding, growing, cultivation, and harvesting of cannabis for others; production of cannabis, namely, cultivation of
cannabis plants, for others; none of the foregoing services featuring or providing cannabis with a delta-9 tetrahydrocannabinol
(THC) concentration of more than 0.3 percent on a dry weight basis
Additional Information
Design Mark
The mark consists of a stylized sideways "V" with three sun rays radiating out from the center of the "V" and to the right of the "V" the stylized word TILRAY above the word MEDICAL.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
031
041
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MEDICAL"